{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:05Z","timestamp":1753891265934,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple systems and classified under connective tissue disorders. Ocular involvement occurs in up to 30% of SLE cases, with the cornea being particularly susceptible to thinning due to immune-complex deposits and its predominantly type I collagen composition. This corneal thinning is clinically significant in glaucoma, where patients with reduced central corneal thickness (CCT) may have up to a threefold increased risk of developing glaucoma, as well as in refractive surgery. However, existing studies on CCT in SLE are limited and marked by substantial heterogeneity in methodology, technology, criteria, and participant numbers, resulting in conflicting findings. Based in our hypothesis that SLE-related corneal lysis may result in decreased CCT, this study aims to determine and compare the mean CCT values between SLE patients and healthy controls to obtain a more precise understanding of the potential relationship.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>A cross-sectional observational study will be conducted, enrolling SLE patients and age-and sex-matched healthy controls recruited from ophthalmology consultations. Exclusion criteria will be applied to rule out other corneal thinning risk factors. A pilot study estimated a minimum sample size of 34 participants per group. CCT measurements will be obtained using Zeiss HD Cirrus 5,000 optical coherence tomography (OCT) on a randomly selected eye, following concordance analysis using the Kappa index. Statistical analysis will include descriptive, bivariate, and multivariate methods. The study protocol was approved by the ethics committee.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The cornea\u2019s vulnerability to thinning and lysis in SLE, which impacts CCT, is crucial for the accurate assessment of glaucoma, the leading cause of irreversible blindness worldwide and the second leading cause in Europe. Given that patients with reduced CCT are at a significantly higher risk of developing glaucoma, further research is necessary to understand the association between SLE and CCT. Our study aims to enhance methodological rigor compared to prior research by determining an appropriate sample size and exclusively enrolling SLE patients to increase participant homogeneity. If a significant difference in CCT between groups and an association between CCT and SLE are found, a prospective study will be considered.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1483930","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:41:13Z","timestamp":1728967273000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between central corneal thickness and systemic lupus erythematosus: a cross-sectional study protocol"],"prefix":"10.3389","volume":"11","author":[{"given":"Juan David","family":"Salda\u00f1a-Garrido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cant\u00f3-Cerd\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente Francisco","family":"Gil-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Alfaro-Beltr\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Sivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10238-017-0479-9","article-title":"Systemic lupus erythematosus and ocular involvement: an overview","volume":"18","author":"Dammacco","year":"2018","journal-title":"Clin Exp Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/BOR.0000000000000198","article-title":"Epidemiology of lupus: an update","volume":"27","author":"Lim","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/eye.2011.99","article-title":"The biomechanical properties of the cornea in patients with systemic lupus erythematosus","volume":"25","author":"Yazici","year":"2011","journal-title":"Eye (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2147\/OPTH.S234568","article-title":"Evaluation of central and peripheral corneal thicknesses in patients with systemic lupus erythematosus","volume":"14","author":"Eissa","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2147\/OPTH.S323673","article-title":"Anterior segment optical coherence tomography of tear film and cornea in systemic lupus erythematosus patients","volume":"15","author":"Mahmoud","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"ref7","first-page":"CR573-8","article-title":"Ocular circulation in systemic lupus erythematosus","volume":"15","author":"Modrzejewska","year":"2009","journal-title":"Med Sci Monit"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/09273948.2018.1501491","article-title":"Quantification of ocular biomechanics in ocular manifestations of systemic autoimmune diseases","volume":"27","author":"Mahendradas","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ophtha.2019.06.029","article-title":"Associations with corneal hysteresis in a population cohort: results from 96 010 UK biobank participants","volume":"126","author":"Zhang","year":"2019","journal-title":"Opththalmology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/15569527.2020.1861003","article-title":"Evaluation of corneal safety in systemic lupus erythematosus patients undergoing long-term hydroxychloroquine treatment","volume":"40","author":"\u00c7a\u011flayan","year":"2021","journal-title":"Cutan Ocul Toxicol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e21467","DOI":"10.1097\/MD.0000000000021467","article-title":"Measurements of scleral thickness and corneal optic densitometry in patients with systemic lupus erythematosus","volume":"99","author":"Kaya","year":"2020","journal-title":"Medicine"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/15569527.2019.1608228","article-title":"Corneal thickness and endothelial changes in long-term hydroxychloroquine use","volume":"38","author":"O\u011furel","year":"2019","journal-title":"Cutan Ocul Toxicol"},{"volume-title":"Basic and clinical science course section 8 external disease and cornea. 2022\u20132023","year":"2022","author":"AAO","key":"ref13"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/OPX.0000000000000974","article-title":"Central corneal thickness reproducibility among ten different instruments","volume":"93","author":"Pierro","year":"2016","journal-title":"Optom Vis Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5935\/0004-2749.20170050","article-title":"Corneal properties and glaucoma: a review of the literature and meta-analysis","volume":"80","author":"Gaspar","year":"2017","journal-title":"Arq Bras Oftalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/IJG.0b013e31824cafc9","article-title":"Influence of corneal biomechanical properties on intraocular pressure differences between an air-puff tonometer and the Goldmann applanation tonometer","volume":"22","author":"Tranchina","year":"2013","journal-title":"J Glaucoma"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of Glaucoma and projections of Glaucoma burden through 2040. A systematic review and Meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"volume-title":"Terminology and guidelines of Glaucoma","year":"2021","key":"ref18"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10792-020-01649-1","article-title":"The effect of long-term hydroxychloroquine use on the corneal endothelium in patients with systemic lupus erythematosus","volume":"41","author":"Vural","year":"2020","journal-title":"Int Ophthalmol"},{"key":"ref20","first-page":"79","article-title":"Lupus Eritemasoso Sist\u00e9mico","volume-title":"EPISER 2016: Estudio de prevalencia de las enfermedades reum\u00e1ticas en poblaci\u00f3n adulta en Espa\u00f1a. Madrid: Sociedad Espa\u00f1ola de Reumatolog\u00eda","author":"FED","year":"2018"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.optom.2016.12.004","article-title":"Accuracy of cirrus HD-OCT and Topcon SP-3000P for measuring central corneal thickness","volume":"11","author":"Calvo-Sanz","year":"2018","journal-title":"J Optom"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1483930\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:41:16Z","timestamp":1728967276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1483930\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":21,"alternative-id":["10.3389\/fmed.2024.1483930"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1483930","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2024,10,15]]},"article-number":"1483930"}}